Will Multiyear Effort Lead to New Cures?
NHGRI Seeks to Capitalize on Genome Sequencing Program
By Marie Powers
Wednesday, December 21, 2011
The National Human Genome Research Institute (NHGRI) recently revealed an ambitious effort to capitalize on its flagship genome sequencing program by pumping $416 million into four areas over four years to find the causes of rare inherited diseases and to accelerate the use of genome sequence information in the medical care of patients.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.